Elutia Inc (ELUT)
3.79
-0.02
(-0.52%)
USD |
NASDAQ |
Oct 04, 16:00
3.74
-0.05
(-1.32%)
After-Hours: 20:00
Elutia SG&A Expense (Annual): 27.19M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 27.19M |
December 31, 2022 | 33.90M |
December 31, 2021 | 32.51M |
Date | Value |
---|---|
December 31, 2020 | 28.21M |
December 31, 2019 | 25.78M |
December 31, 2018 | 21.68M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
25.78M
Minimum
2019
33.90M
Maximum
2022
29.52M
Average
28.21M
Median
2020
SG&A Expense (Annual) Benchmarks
Perspective Therapeutics Inc | 21.06M |
Retractable Technologies Inc | 20.01M |
InfuSystems Holdings Inc | 58.03M |
Xtant Medical Holdings Inc | 64.29M |
Catheter Precision Inc | 17.12M |